Cytek Biosciences, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC CTKB

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

832

Value ($000)

4

Weight

0.0%

2022 Q2 - 2025 Q4 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	4	0.0%	832	12/31/2025
2025 Q2	8/14/2025	967	0.0%	284,350	6/30/2025
2025 Q1	5/19/2025	768	0.0%	191,624	3/31/2025
2024 Q4	2/14/2025	1,279	0.0%	197,058	12/31/2024
2024 Q3	11/14/2024	967	0.0%	174,625	9/30/2024
2024 Q2	8/14/2024	1,111	0.0%	199,153	6/30/2024
2024 Q1	5/15/2024	833	0.0%	124,131	3/31/2024
2023 Q4	2/14/2024	1,123	0.0%	123,116	12/31/2023
2023 Q3	11/13/2023	616	0.0%	111,523	9/30/2023
2023 Q2	8/11/2023	589	0.0%	64,095	6/30/2023
2023 Q1	5/15/2023	589	0.0%	64,095	3/31/2023
2022 Q4	2/14/2023	644	0.0%	63,032	12/31/2022
2022 Q3	11/14/2022	1,028	0.0%	69,822	9/30/2022
2022 Q2	8/12/2022	686	0.0%	63,957	6/30/2022